San Antonio / Montreal / New York / Therapy / Program / New Orleans / Calgary / Chicago / Durham / /
Company
Good Manufacturing / Baxter / Osiris Therapeutics Inc. / /
Country
Canada / Columbia / /
Facility
Children’s Hospital of Wisconsin / Lurie Children’s Hospital of Chicago / Texas Transplant Institute / Medical College of Wisconsin / Memorial Sloan Kettering Cancer Center / Science University / LSU Health Science Center / Alberta Children’s Hospital / Methodist Children’s Hospital of South Texas / Children’s Hospital / Duke University Medical Center / University of California / /
Medical College of Wisconsin / Milwaukee / Alberta Children’s Hospital / MD SC / RI PT / Department of Pediatrics / Methodist Children’s Hospital of South Texas / SC RI PT / Texas Transplant Institute / Oregon Health & Science University / Portland / Children’s Hospital of Wisconsin / Robert H. Lurie Children’s Hospital of Chicago / LSU Health Science Center / Memorial Sloan Kettering Cancer Center / FDA / University of California / San Francisco / Duke University Medical Center / /
Person
Eneida Nemecek / Lewis V / Lolie Yu / Victor Lewis / R. Mills / Ka Wah Chan / Biljana Horn / Sonali Chaudhury / Pierre Teira / Charles R. Mills / Julie-An Talano / Henrique Bittencourt / Susan Prockop / /
Allogeneic Human Mesenchymal Stem Cell Therapy (remestemcel-L, Prochymal®) as a Rescue Agent for Severe Refractory Acute GvHD in Pediatric Patients